PuSH - Publication Server of Helmholtz Zentrum München

Bornstein, S.R.* ; Malyukov, M.* ; Heller, C. ; Ziegler, C.G.* ; Ruiz-Babot, G.* ; Schedl, A.* ; Ludwig, B. ; Steenblock, C.*

New horizons: Novel adrenal regenerative therapies.

J. Clin. Endocrinol. Metab. 105, 3103-3107 (2020)
Publ. Version/Full Text Postprint DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
Adrenal insufficiency requires lifelong corticoid replacement therapies. However, current therapies are not able to replace the physiological circadian pattern of the adrenal cortex and are associated with many metabolic, vascular, neuroendocrine, and mental perturbations. Therefore, regenerative and more curative strategies would be desirable. In the current perspective, we describe emerging new regenerative therapies for the treatment of adrenal insufficiency. In particular, we discuss gene therapy and cell replacement strategies. Furthermore, we discuss how adrenal cells might be used as a source for regenerative therapies of nonadrenal neurodegenerative diseases such as Parkinson disease.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Corresponding Author
Keywords Adrenal ; Stem Cells ; Adrenal Insufficiency ; Cell Replacement ; Gene Therapy ; Regenerative Therapies
ISSN (print) / ISBN 0021-972X
e-ISSN 1945-7197
Quellenangaben Volume: 105, Issue: 9, Pages: 3103-3107 Article Number: , Supplement: ,
Publisher Endocrine Society
Publishing Place Bethesda, Md.
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Pancreatic Islet Research (IPI)
Grants Deutsche Forschungsgemeinschaft (DFG, German Research foundation)